Scientific Events

A vital element of Clinuvel’s development program is maintaining close contact with research being conducted across the fields in which we work. As well as hosting our Annual Scientific and Clinical Excellence Meeting (ASCEM), the Clinuvel team supports and attends a number of global and regional scientific events annually. This page is periodically updated with further events relevant to Clinuvel's clinical program.

2013 Scientific Events

February 28-March 1
Le Malattie Rare all’Istituto San Gallicano, Rome, Italy

March 1-5
American Academy of Dermatology Annual Meeting (website), Miami Beach, USA

May 7
1st IID Satellite Symposium on “Dermatoendocrinology” (website), Edinburgh, Scotland

May 16-18
International Congress of Porphyrins & Porphyrias (website), Lucerne, Switzerland

May 17-19
Asian Society for Pigment Cell Research meeting (website), Sydney, Australia

May 18-22
2013 Australasian College of Dermatologists 46th Annual Scientific Meeting, Sydney

2012 Scientific Events

February 20-23
Australasia Regional Conference of Dermatology (website), Philippines

March 16-20
70th Annual Meeting of the American Academy of Dermatology (website), San Diego, US

June 6-10
European Academy of Dermatology and Venereology Spring Symposium (website), Verona, Italy

September 14-17
17th Annual Meeting of the European Society for Pigment Cell Research (website), Geneva, Switzerland

September 27-30
21st Congress of the European Academy of Dermatology and Venereology (website), Prague, Czech Republic

2011 Scientific Events

January 23-24
Clinuvel's third Annual Scientific and Clinical Excellence Meeting (ASCEM III), Luzern, Switzerland (read the company's announcement)

February 4-8
69th Annual Meeting of the American Academy of Dermatology (website), New Orleans, US

April 10-13
Porphyrias and Porphyrins 2011, Cardiff, Wales

May 24-29
22nd World Congress of Dermatology (website), Seoul, Korea

September 21-24
XXIst International Pigment Cell Conference (website), Bordeaux, France

October 20-24
20th Congress of the European Academy of Dermatology and Venereology (website) including the Alpha-MSH Society Subspecialty Meeting (October 20), Lisbon, Portugal

Normal 0 false false false EN-AU X-NONE X-NONE

Clinuvel Blog Posts

Today, February 28, marks Rare Disease Day: an annual event to help highlight the effects of rare diseases on individuals, families and the...

Read More

We've just released the first results from our vitiligo program which you can view online here. Following their release, we expect a number...

Read More

I find vitiligo to be a fascinating, yet devastating disorder: almost overnight, patients see their skin colour erode and their identity...

Read More

Clinuvel Webcasts

Taking on Vitiligo, a depigmentation disorder of the skin. In 2010, Clinuvel ventured into an area of dermatology where no other pharmaceut...

Watch now

Taking on Vitiligo, a depigmentation disorder of the skin. In 2010, Clinuvel ventured into an area of dermatology where no other pharmaceut...

Watch now

Taking on Vitiligo, a depigmentation disorder of the skin. In 2010, Clinuvel ventured into an area of dermatology where no other pharmaceut...

Watch now

Clinuvel Spotlight

The technology behind Clinuvel’s lead drug, SCENESSE® (afamelanotide), has been in research and development since the 1980s when a small team of scientists set out to investigate methods of preventing skin cancer in humans. Clinuvel licensed this technology and has spent over A$20million optimising the chemistry of afamelanotide (the active ingredient in SCENESSE®) an...

Read more